GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integer Holdings Corp (NYSE:ITGR) » Definitions » PE Ratio without NRI

Integer Holdings (Integer Holdings) PE Ratio without NRI : 28.66 (As of Apr. 26, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Integer Holdings PE Ratio without NRI?

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2024-04-26), Integer Holdings's share price is $111.15. Integer Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $3.88. Therefore, Integer Holdings's PE Ratio without NRI for today is 28.66.

During the past 13 years, Integer Holdings's highest PE Ratio without NRI was 41.44. The lowest was 6.98. And the median was 20.21.

Integer Holdings's EPS without NRI for the three months ended in Dec. 2023 was $1.39. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $3.88.

As of today (2024-04-26), Integer Holdings's share price is $111.15. Integer Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.69. Therefore, Integer Holdings's PE Ratio for today is 41.32.

During the past years, Integer Holdings's highest PE Ratio was 487.00. The lowest was 11.86. And the median was 29.84.

Integer Holdings's EPS (Diluted) for the three months ended in Dec. 2023 was $0.78. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.69.

Integer Holdings's EPS (Basic) for the three months ended in Dec. 2023 was $0.79. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.72.


Integer Holdings PE Ratio without NRI Historical Data

The historical data trend for Integer Holdings's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integer Holdings PE Ratio without NRI Chart

Integer Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.89 35.85 28.50 28.89 21.22

Integer Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.89 26.87 26.70 21.80 21.22

Competitive Comparison of Integer Holdings's PE Ratio without NRI

For the Medical Devices subindustry, Integer Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integer Holdings's PE Ratio without NRI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Integer Holdings's PE Ratio without NRI falls into.



Integer Holdings PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Integer Holdings's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=111.15/3.878
=28.66

Integer Holdings's Share Price of today is $111.15.
Integer Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.88.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Integer Holdings  (NYSE:ITGR) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Integer Holdings PE Ratio without NRI Related Terms

Thank you for viewing the detailed overview of Integer Holdings's PE Ratio without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Integer Holdings (Integer Holdings) Business Description

Traded in Other Exchanges
Address
5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.
Executives
Donald J Spence director C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304
Jean M. Hobby director 10000 WEHRLE DRIVE, CLARENCE NY 14031
Jim Stephens officer: President, CRM & Neuro 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Diron Smith officer: VP, Interim CFO 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph W Dziedzic director 1801 BAYBERRY COURT, RICHMOND VA 23226
Pamela G Bailey director 1200 G ST NW, STE 400, WASHINGTON DC 20005-3814
Jennifer M Bolt officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Carter Houghton officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Andrew Senn officer: SVP, Strategy and Business Dev 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Marshall Mcalister C Ii officer: SVP, Gen Counsel & Secretary 1801 BAYBERRY COURT, P.O. BOX 18100, RICHMOND VA 23226
Margaret Carthy officer: SVP, Quality & Regulatory Affa 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph F Flanagan officer: EVP, Quality & Regulatory Affa 10000 WEHRLE DRIVE, CLARENCE NY 14031
Bill R Sanford director 2617 BULRUSH LANE, NAPLES FL 34105
Anthony W Borowicz officer: SVP Strategy,Corp Dev., IR 10000 WEHRLE DRIVE, CLARENCE NY 14031
Sheila Antrum director 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024